Publication | Open Access
Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
12
Citations
13
References
2022
Year
Famitinib can synergize with radioimmunotherapy by regulating the tumor immune microenvironment in murine lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1